Skip to content

Effect of lasix in postpartum hypertension

Effect of lasix in post partum hypertention in mild preeclampsia pregnant women refferd to Khalije Fars hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181218042033N3
Enrollment
120
Registered
2020-03-03
Start date
2017-05-31
Completion date
Unknown
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia in postpartum patients. Mild to moderate pre-eclampsia

Interventions

Intervention 1: Intervention group: oral furosemide tablets 20 mg (half a tablet) daily, manufactured by Kimia daroo Pharmaceutical Company for 5 days. Intervention 2: Control group: placebo (half a t

Sponsors

Bandare-abbas University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Diagnosis of preeclampsia Age of 18-50 years Having a systolic blood pressure of 140-159 for at least 2 times or a diastolic blood pressure of 90-109 every four hours within 24 hours of the surgery

Exclusion criteria

Exclusion criteria: History of chronic blood pressure History of renal problems History of liver disease History of diabetes History of cardiovascular History of experience of smoking Allergy to the target medication Multiple pregnancy

Design outcomes

Primary

MeasureTime frame
The measure of patient's Systolic blood pressure that should be between 140 to 159 mm Hg. Timepoint: Blood pressure measurement in the 1, 3 , 5 days intervention and then a week later. Method of measurement: Mercury barometric device.;The measure of patient's diastolic blood pressure that should be between 90 to 109 mm Hg. Timepoint: Blood pressure measurement in the 1, 3 , 5 days intervention and then a week later. Method of measurement: Mercury barometric device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNarges Ghasemi

Bandare-abbas University of Medical Sciences

abdinazanin834@gmail.com+98 76 3647 9830

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026